Search research articles
Contact Us
Filters
Showing results (11-20 of 50) with videos related to
Page
of 5
Sort By:
Archiv Der Pharmazie
|
June 19, 2024
Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy-coupling factor transporters (ECFTs)
Jörg Haupenthal, Muhammad Rafehi, Andreas M Kany, et al.
ACS Infectious Diseases
|
February 28, 2018
Binding Mode Characterization and Early in Vivo Evaluation of Fragment-Like Thiols as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa
Andreas M Kany, Asfandyar Sikandar, Jörg Haupenthal, et al.
Seizure
|
November 21, 2013
Bilateral Wada test: amobarbital or propofol?
J Curot, M Denuelle, T Busigny, et al.
European Journal of Medicinal Chemistry
|
February 13, 2026
Identification of a new protein-RNA interaction inhibitor targeting the KH34 region of the insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2/IMP2)
Aylin Berwanger, Konrad Wagner, Simon Both, et al.
Chemical Science
|
August 2, 2024
Isocyanides inhibit bacterial pathogens by covalent targeting of essential metabolic enzymes
Alexandra Geißler, Howard Junca, Andreas M Kany, et al.
Chemmedchem
|
May 19, 2021
Structure-Activity Relationship and Mode-Of-Action Studies Highlight 1-(4-Biphenylylmethyl)-1H-imidazole-Derived Small Molecules as Potent CYP121 Inhibitors
Isabell Walter, Sebastian Adam, Maria Virginia Gentilini, et al.
Chemmedchem
|
November 12, 2019
Flexible Fragment Growing Boosts Potency of Quorum-Sensing Inhibitors against Pseudomonas aeruginosa Virulence
Michael Zender, Florian Witzgall, Alexander Kiefer, et al.
European Journal of Medicinal Chemistry
|
September 14, 2021
Divergent synthesis and biological evaluation of 2-(trifluoromethyl)pyridines as virulence-attenuating inverse agonists targeting PqsR
Christian Schütz, Amir Hodzic, Mostafa Hamed, et al.
JACS Au
|
December 26, 2025
Engineering an Artificial Myxopyronin Derivative with Enhanced Metabolic Stability via Mutasynthesis
Alexander F Kiefer, Alexander Voltz, Domen Scherzer, et al.
Journal of Medicinal Chemistry
|
July 28, 2023
Disrupting Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Latent Replication with a Small Molecule Inhibitor
Aylin Berwanger, Saskia C Stein, Andreas M Kany, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 50) with videos related to
Sort By:
Page
of 5
Archiv Der Pharmazie
|
June 19, 2024
Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy-coupling factor transporters (ECFTs)
Jörg Haupenthal, Muhammad Rafehi, Andreas M Kany, et al.
ACS Infectious Diseases
|
February 28, 2018
Binding Mode Characterization and Early in Vivo Evaluation of Fragment-Like Thiols as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa
Andreas M Kany, Asfandyar Sikandar, Jörg Haupenthal, et al.
Seizure
|
November 21, 2013
Bilateral Wada test: amobarbital or propofol?
J Curot, M Denuelle, T Busigny, et al.
European Journal of Medicinal Chemistry
|
February 13, 2026
Identification of a new protein-RNA interaction inhibitor targeting the KH34 region of the insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2/IMP2)
Aylin Berwanger, Konrad Wagner, Simon Both, et al.
Chemical Science
|
August 2, 2024
Isocyanides inhibit bacterial pathogens by covalent targeting of essential metabolic enzymes
Alexandra Geißler, Howard Junca, Andreas M Kany, et al.
Chemmedchem
|
May 19, 2021
Structure-Activity Relationship and Mode-Of-Action Studies Highlight 1-(4-Biphenylylmethyl)-1H-imidazole-Derived Small Molecules as Potent CYP121 Inhibitors
Isabell Walter, Sebastian Adam, Maria Virginia Gentilini, et al.
Chemmedchem
|
November 12, 2019
Flexible Fragment Growing Boosts Potency of Quorum-Sensing Inhibitors against Pseudomonas aeruginosa Virulence
Michael Zender, Florian Witzgall, Alexander Kiefer, et al.
European Journal of Medicinal Chemistry
|
September 14, 2021
Divergent synthesis and biological evaluation of 2-(trifluoromethyl)pyridines as virulence-attenuating inverse agonists targeting PqsR
Christian Schütz, Amir Hodzic, Mostafa Hamed, et al.
JACS Au
|
December 26, 2025
Engineering an Artificial Myxopyronin Derivative with Enhanced Metabolic Stability via Mutasynthesis
Alexander F Kiefer, Alexander Voltz, Domen Scherzer, et al.
Journal of Medicinal Chemistry
|
July 28, 2023
Disrupting Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Latent Replication with a Small Molecule Inhibitor
Aylin Berwanger, Saskia C Stein, Andreas M Kany, et al.
Page
of 5